World news, news around town, tech update 3
Ad
Tuesday, 18 April 2017
Circassia gives up on allergy after house dust mite study fails
LONDON (Reuters) - Britain's Circassia Pharmaceuticals said on Tuesday it was halting allergy investment after an immunotherapy clinical study in house dust mite allergy failed.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment